abstract |
The present invention, in particular, provides a composition and method for CNS delivery of a human recombinant iduronate-2-sulfatase protein, idusulfase-beta, for effective treatment of Hunter syndrome. The compositions and methods provided by the present invention effectively reduce symptoms in the brain and spinal cord, as well as in peripheral tissues including the heart, liver, spleen, lungs and kidneys. |